Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
2151
Agenus
AGEN
$315M
| $7.79M | ﹤0.01% |
75,587
+9,355
| +14% | +$1.06M |
|
2152
Gogo Inc
GOGO
$377M
| $7.79M | ﹤0.01% |
450,077
+81,956
| +22% | +$992K |
|
2153
Nurix Therapeutics
NRIX
$2.82B
| $7.78M | ﹤0.01% |
259,760
+129,872
| +100% | +$4.01M |
|
2154
StoneX
SNEX
$8.05B
| $7.77M | ﹤0.01% |
596,828
+11,735
| +2% | +$151K |
|
2155
Veeco
VECO
$3.28B
| $7.75M | ﹤0.01% |
348,904
+3,720
| +1% | +$82.9K |
|
2156
Argan
AGX
$7.84B
| $7.74M | ﹤0.01% |
177,313
+10,565
| +6% | +$478K |
|
2157
Comtech Telecommunications
CMTL
$52.7M
| $7.72M | ﹤0.01% |
301,258
+2,195
| +0.7% | +$55.1K |
|
2158
Resources Connection
RGP
$145M
| $7.68M | ﹤0.01% |
486,590
+18,693
| +4% | +$281K |
|
2159
Dime Commercial Bancshares
DCOM
$1.82B
| $7.68M | ﹤0.01% |
234,997
-10,088
| -4% | -$327K |
|
|
BRSP
2160
BrightSpire Capital
BRSP
$629M
| $7.64M | ﹤0.01% |
814,163
+131,522
| +19% | +$1.27M |
|
|
GBIO
2161
DELISTED
Generation Bio
GBIO
| $7.64M | ﹤0.01% |
30,491
+11,102
| +57% | +$2.66M |
|
2162
Gates Industrial Corporation Ltd.
GTES
$7B
| $7.63M | ﹤0.01% |
468,639
+141,802
| +43% | +$2.43M |
|
|
LDL
2163
DELISTED
Lydall, Inc.
LDL
| $7.63M | ﹤0.01% |
122,785
+4,779
| +4% | +$294K |
|
|
EBIX
2164
DELISTED
Ebix Inc
EBIX
| $7.61M | ﹤0.01% |
282,642
+16,747
| +6% | +$491K |
|
2165
Brown-Forman Class A
BF.A
$13.1B
| $7.61M | ﹤0.01% |
121,410
+1,018
| +0.8% | +$67.9K |
|
|
CVGW
2166
DELISTED
Calavo Growers
CVGW
| $7.57M | ﹤0.01% |
197,863
+23,376
| +13% | +$1.17M |
|
|
SLCA
2167
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.56M | ﹤0.01% |
945,686
-142,643
| -13% | -$1.35M |
|
2168
MannKind Corp
MNKD
$1.2B
| $7.55M | ﹤0.01% |
1,736,760
+27,378
| +2% | +$123K |
|
2169
Scorpio Tankers
STNG
$3.93B
| $7.54M | ﹤0.01% |
406,650
+37,707
| +10% | +$629K |
|
2170
Globalstar
GSAT
$10.7B
| $7.54M | ﹤0.01% |
300,765
+4,846
| +2% | +$119K |
|
2171
Center Bancorp
CNOB
$1.81B
| $7.53M | ﹤0.01% |
250,813
+6,619
| +3% | +$183K |
|
2172
Coherus Oncology
CHRS
$176M
| $7.51M | ﹤0.01% |
467,358
-8,320
| -2% | -$122K |
|
|
QADA
2173
DELISTED
QAD Inc.
QADA
| $7.5M | ﹤0.01% |
85,777
+2,889
| +3% | +$252K |
|
|
VTLE
2174
DELISTED
Vital Energy
VTLE
| $7.5M | ﹤0.01% |
92,447
+20,204
| +28% | +$1.24M |
|
2175
Seaboard Corp
SEB
$4.08B
| $7.47M | ﹤0.01% |
1,822
+33
| +2% | +$133K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.